Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Global Anti-Tuberculosis Drug Market Growth 2024-2030

Report ID: 2901309 | Published Date: Jun 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Anti-Tuberculosis Drug Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Anti-Tuberculosis Drug by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Anti-Tuberculosis Drug by Country/Region, 2019, 2023 & 2030

    2.2 Anti-Tuberculosis Drug Segment by Type

        2.2.1 First-Line Anti-Tuberculosis Drugs

        2.2.2 Second-Line Anti-Tuberculosis Drugs

    2.3 Anti-Tuberculosis Drug Sales by Type

        2.3.1 Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

        2.3.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024)

    2.4 Anti-Tuberculosis Drug Segment by Application

        2.4.1 Hospital

        2.4.2 Clinic

        2.4.3 Others

    2.5 Anti-Tuberculosis Drug Sales by Application

        2.5.1 Global Anti-Tuberculosis Drug Sale Market Share by Application (2019-2024)

        2.5.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024)

3 Global Anti-Tuberculosis Drug by Company

    3.1 Global Anti-Tuberculosis Drug Breakdown Data by Company

        3.1.1 Global Anti-Tuberculosis Drug Annual Sales by Company (2019-2024)

        3.1.2 Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)

    3.2 Global Anti-Tuberculosis Drug Annual Revenue by Company (2019-2024)

        3.2.1 Global Anti-Tuberculosis Drug Revenue by Company (2019-2024)

        3.2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)

    3.3 Global Anti-Tuberculosis Drug Sale Price by Company

    3.4 Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Anti-Tuberculosis Drug Product Location Distribution

        3.4.2 Players Anti-Tuberculosis Drug Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Tuberculosis Drug by Geographic Region

    4.1 World Historic Anti-Tuberculosis Drug Market Size by Geographic Region (2019-2024)

        4.1.1 Global Anti-Tuberculosis Drug Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Anti-Tuberculosis Drug Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Anti-Tuberculosis Drug Market Size by Country/Region (2019-2024)

        4.2.1 Global Anti-Tuberculosis Drug Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Anti-Tuberculosis Drug Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Anti-Tuberculosis Drug Sales Growth

    4.4 APAC Anti-Tuberculosis Drug Sales Growth

    4.5 Europe Anti-Tuberculosis Drug Sales Growth

    4.6 Middle East & Africa Anti-Tuberculosis Drug Sales Growth

5 Americas

    5.1 Americas Anti-Tuberculosis Drug Sales by Country

        5.1.1 Americas Anti-Tuberculosis Drug Sales by Country (2019-2024)

        5.1.2 Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024)

    5.2 Americas Anti-Tuberculosis Drug Sales by Type

    5.3 Americas Anti-Tuberculosis Drug Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Anti-Tuberculosis Drug Sales by Region

        6.1.1 APAC Anti-Tuberculosis Drug Sales by Region (2019-2024)

        6.1.2 APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024)

    6.2 APAC Anti-Tuberculosis Drug Sales by Type

    6.3 APAC Anti-Tuberculosis Drug Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Anti-Tuberculosis Drug by Country

        7.1.1 Europe Anti-Tuberculosis Drug Sales by Country (2019-2024)

        7.1.2 Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024)

    7.2 Europe Anti-Tuberculosis Drug Sales by Type

    7.3 Europe Anti-Tuberculosis Drug Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Anti-Tuberculosis Drug by Country

        8.1.1 Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024)

    8.2 Middle East & Africa Anti-Tuberculosis Drug Sales by Type

    8.3 Middle East & Africa Anti-Tuberculosis Drug Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug

    10.3 Manufacturing Process Analysis of Anti-Tuberculosis Drug

    10.4 Industry Chain Structure of Anti-Tuberculosis Drug

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Anti-Tuberculosis Drug Distributors

    11.3 Anti-Tuberculosis Drug Customer

12 World Forecast Review for Anti-Tuberculosis Drug by Geographic Region

    12.1 Global Anti-Tuberculosis Drug Market Size Forecast by Region

        12.1.1 Global Anti-Tuberculosis Drug Forecast by Region (2025-2030)

        12.1.2 Global Anti-Tuberculosis Drug Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Anti-Tuberculosis Drug Forecast by Type

    12.7 Global Anti-Tuberculosis Drug Forecast by Application

13 Key Players Analysis

    13.1 Lupin

        13.1.1 Lupin Company Information

        13.1.2 Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Lupin Main Business Overview

        13.1.5 Lupin Latest Developments

    13.2 Otsuka

        13.2.1 Otsuka Company Information

        13.2.2 Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 Otsuka Main Business Overview

        13.2.5 Otsuka Latest Developments

    13.3 Sanofi

        13.3.1 Sanofi Company Information

        13.3.2 Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Sanofi Main Business Overview

        13.3.5 Sanofi Latest Developments

    13.4 Prizer

        13.4.1 Prizer Company Information

        13.4.2 Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Prizer Main Business Overview

        13.4.5 Prizer Latest Developments

    13.5 Abbott

        13.5.1 Abbott Company Information

        13.5.2 Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Abbott Main Business Overview

        13.5.5 Abbott Latest Developments

    13.6 NOVARTIS

        13.6.1 NOVARTIS Company Information

        13.6.2 NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications

        13.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 NOVARTIS Main Business Overview

        13.6.5 NOVARTIS Latest Developments

14 Research Findings and Conclusion

List of Tables

    Table 1. Anti-Tuberculosis Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Anti-Tuberculosis Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of First-Line Anti-Tuberculosis Drugs

    Table 4. Major Players of Second-Line Anti-Tuberculosis Drugs

    Table 5. Global Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)

    Table 6. Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

    Table 7. Global Anti-Tuberculosis Drug Revenue by Type (2019-2024) & ($ million)

    Table 8. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)

    Table 9. Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024) & (US$/Unit)

    Table 10. Global Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)

    Table 11. Global Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)

    Table 12. Global Anti-Tuberculosis Drug Revenue by Application (2019-2024)

    Table 13. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2019-2024)

    Table 14. Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024) & (US$/Unit)

    Table 15. Global Anti-Tuberculosis Drug Sales by Company (2019-2024) & (K Units)

    Table 16. Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)

    Table 17. Global Anti-Tuberculosis Drug Revenue by Company (2019-2024) ($ Millions)

    Table 18. Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)

    Table 19. Global Anti-Tuberculosis Drug Sale Price by Company (2019-2024) & (US$/Unit)

    Table 20. Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution and Sales Area

    Table 21. Players Anti-Tuberculosis Drug Products Offered

    Table 22. Anti-Tuberculosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 23. New Products and Potential Entrants

    Table 24. Mergers & Acquisitions, Expansion

    Table 25. Global Anti-Tuberculosis Drug Sales by Geographic Region (2019-2024) & (K Units)

    Table 26. Global Anti-Tuberculosis Drug Sales Market Share Geographic Region (2019-2024)

    Table 27. Global Anti-Tuberculosis Drug Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 28. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region (2019-2024)

    Table 29. Global Anti-Tuberculosis Drug Sales by Country/Region (2019-2024) & (K Units)

    Table 30. Global Anti-Tuberculosis Drug Sales Market Share by Country/Region (2019-2024)

    Table 31. Global Anti-Tuberculosis Drug Revenue by Country/Region (2019-2024) & ($ millions)

    Table 32. Global Anti-Tuberculosis Drug Revenue Market Share by Country/Region (2019-2024)

    Table 33. Americas Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)

    Table 34. Americas Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)

    Table 35. Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)

    Table 37. Americas Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)

    Table 38. Americas Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)

    Table 39. APAC Anti-Tuberculosis Drug Sales by Region (2019-2024) & (K Units)

    Table 40. APAC Anti-Tuberculosis Drug Sales Market Share by Region (2019-2024)

    Table 41. APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024) & ($ Millions)

    Table 42. APAC Anti-Tuberculosis Drug Revenue Market Share by Region (2019-2024)

    Table 43. APAC Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)

    Table 44. APAC Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)

    Table 45. Europe Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)

    Table 46. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)

    Table 47. Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 48. Europe Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)

    Table 49. Europe Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)

    Table 50. Europe Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)

    Table 51. Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)

    Table 52. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)

    Table 53. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 54. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)

    Table 55. Middle East & Africa Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)

    Table 56. Middle East & Africa Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)

    Table 57. Key Market Drivers & Growth Opportunities of Anti-Tuberculosis Drug

    Table 58. Key Market Challenges & Risks of Anti-Tuberculosis Drug

    Table 59. Key Industry Trends of Anti-Tuberculosis Drug

    Table 60. Anti-Tuberculosis Drug Raw Material

    Table 61. Key Suppliers of Raw Materials

    Table 62. Anti-Tuberculosis Drug Distributors List

    Table 63. Anti-Tuberculosis Drug Customer List

    Table 64. Global Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)

    Table 65. Global Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 66. Americas Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 67. Americas Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 68. APAC Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)

    Table 69. APAC Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 70. Europe Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 71. Europe Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 72. Middle East & Africa Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 73. Middle East & Africa Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 74. Global Anti-Tuberculosis Drug Sales Forecast by Type (2025-2030) & (K Units)

    Table 75. Global Anti-Tuberculosis Drug Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 76. Global Anti-Tuberculosis Drug Sales Forecast by Application (2025-2030) & (K Units)

    Table 77. Global Anti-Tuberculosis Drug Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 78. Lupin Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 79. Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 80. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 81. Lupin Main Business

    Table 82. Lupin Latest Developments

    Table 83. Otsuka Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 84. Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 85. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 86. Otsuka Main Business

    Table 87. Otsuka Latest Developments

    Table 88. Sanofi Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 89. Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 90. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 91. Sanofi Main Business

    Table 92. Sanofi Latest Developments

    Table 93. Prizer Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 94. Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 95. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 96. Prizer Main Business

    Table 97. Prizer Latest Developments

    Table 98. Abbott Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 99. Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 100. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 101. Abbott Main Business

    Table 102. Abbott Latest Developments

    Table 103. NOVARTIS Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors

    Table 104. NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications

    Table 105. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 106. NOVARTIS Main Business

    Table 107. NOVARTIS Latest Developments

List of Figures

    Figure 1. Picture of Anti-Tuberculosis Drug

    Figure 2. Anti-Tuberculosis Drug Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Anti-Tuberculosis Drug Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Anti-Tuberculosis Drug Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Anti-Tuberculosis Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of First-Line Anti-Tuberculosis Drugs

    Figure 10. Product Picture of Second-Line Anti-Tuberculosis Drugs

    Figure 11. Global Anti-Tuberculosis Drug Sales Market Share by Type in 2023

    Figure 12. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)

    Figure 13. Anti-Tuberculosis Drug Consumed in Hospital

    Figure 14. Global Anti-Tuberculosis Drug Market: Hospital (2019-2024) & (K Units)

    Figure 15. Anti-Tuberculosis Drug Consumed in Clinic

    Figure 16. Global Anti-Tuberculosis Drug Market: Clinic (2019-2024) & (K Units)

    Figure 17. Anti-Tuberculosis Drug Consumed in Others

    Figure 18. Global Anti-Tuberculosis Drug Market: Others (2019-2024) & (K Units)

    Figure 19. Global Anti-Tuberculosis Drug Sales Market Share by Application (2023)

    Figure 20. Global Anti-Tuberculosis Drug Revenue Market Share by Application in 2023

    Figure 21. Anti-Tuberculosis Drug Sales Market by Company in 2023 (K Units)

    Figure 22. Global Anti-Tuberculosis Drug Sales Market Share by Company in 2023

    Figure 23. Anti-Tuberculosis Drug Revenue Market by Company in 2023 ($ Million)

    Figure 24. Global Anti-Tuberculosis Drug Revenue Market Share by Company in 2023

    Figure 25. Global Anti-Tuberculosis Drug Sales Market Share by Geographic Region (2019-2024)

    Figure 26. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region in 2023

    Figure 27. Americas Anti-Tuberculosis Drug Sales 2019-2024 (K Units)

    Figure 28. Americas Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)

    Figure 29. APAC Anti-Tuberculosis Drug Sales 2019-2024 (K Units)

    Figure 30. APAC Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)

    Figure 31. Europe Anti-Tuberculosis Drug Sales 2019-2024 (K Units)

    Figure 32. Europe Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)

    Figure 33. Middle East & Africa Anti-Tuberculosis Drug Sales 2019-2024 (K Units)

    Figure 34. Middle East & Africa Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)

    Figure 35. Americas Anti-Tuberculosis Drug Sales Market Share by Country in 2023

    Figure 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country in 2023

    Figure 37. Americas Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

    Figure 38. Americas Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)

    Figure 39. United States Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 40. Canada Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Mexico Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Brazil Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 43. APAC Anti-Tuberculosis Drug Sales Market Share by Region in 2023

    Figure 44. APAC Anti-Tuberculosis Drug Revenue Market Share by Regions in 2023

    Figure 45. APAC Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

    Figure 46. APAC Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)

    Figure 47. China Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 48. Japan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 49. South Korea Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 50. Southeast Asia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 51. India Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 52. Australia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 53. China Taiwan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 54. Europe Anti-Tuberculosis Drug Sales Market Share by Country in 2023

    Figure 55. Europe Anti-Tuberculosis Drug Revenue Market Share by Country in 2023

    Figure 56. Europe Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

    Figure 57. Europe Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)

    Figure 58. Germany Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 59. France Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 60. UK Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 61. Italy Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Russia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country in 2023

    Figure 64. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country in 2023

    Figure 65. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)

    Figure 66. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)

    Figure 67. Egypt Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 68. South Africa Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 69. Israel Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Turkey Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 71. GCC Country Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 72. Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug in 2023

    Figure 73. Manufacturing Process Analysis of Anti-Tuberculosis Drug

    Figure 74. Industry Chain Structure of Anti-Tuberculosis Drug

    Figure 75. Channels of Distribution

    Figure 76. Global Anti-Tuberculosis Drug Sales Market Forecast by Region (2025-2030)

    Figure 77. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Region (2025-2030)

    Figure 78. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Type (2025-2030)

    Figure 79. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Type (2025-2030)

    Figure 80. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Application (2025-2030)

    Figure 81. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Application (2025-2030)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
 Lupin|||Otsuka|||Sanofi|||Prizer|||Abbott|||NOVARTIS 
Frequently Asked Questions
Anti-Tuberculosis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Tuberculosis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Tuberculosis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports